S. Costa's Profile

Role	Title	Level	Year	L/R
🐜	Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial. 26 auth. G. von Minckwitz, A. Schneeweiss, S. Loibl, C. Salat, C. Denkert, M. Rezai, J. Blohmer, C. Jackisch, S. Paepke, B. Gerber, D. Zahm, S. Kümmel, H. Eidtmann, P. Klare, J. Huober, ... S. Costa, H. Tesch, C. Hanusch, J. Hilfrich, F. Khandan, P. Fasching, B. Sinn, K. Engels, K. Mehta, V. Nekljudova, M. Untch	9	2014	9 🐜
🐜	Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial 28 auth. E. Hahnen, B. Lederer, J. Hauke, S. Loibl, S. Kröber, A. Schneeweiss, C. Denkert, P. Fasching, J. Blohmer, C. Jackisch, S. Paepke, B. Gerber, S. Kümmel, C. Schem, G. Neidhardt, ... J. Huober, K. Rhiem, S. Costa, J. Altmüller, C. Hanusch, H. Thiele, V. Müller, P. Nürnberg, T. Karn, V. Nekljudova, M. Untch, G. von Minckwitz, R. Schmutzler	8	2017	8 🐜
🐜	Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 166 auth. R. Gray, R. Bradley, J. Braybrooke, Zulian Liu, R. Peto, L. Davies, D. Dodwell, P. Mcgale, H. Pan, Carolyn Taylor, W. Barlow, J. Bliss, P. Bruzzi, D. Cameron, G. Fountzilas, ... S. Loibl, J. Mackey, Miguel Martín, L. Del Mastro, V. Möbus, V. Nekljudova, S. De Placido, S. Swain, M. Untch, K. Pritchard, J. Bergh, L. Norton, Clare Boddington, J. Burrett, M. Clarke, C. Davies, F. Duane, V. Evans, Lucy Gettins, J. Godwin, R. Hills, S. James, Hui Liu, E. Mackinnon, G. Mannu, T. McHugh, P. Morris, Simon Read, Yaochen Wang, Zhe Wang, P. Fasching, N. Harbeck, P. Piedbois, M. Gnant, G. Steger, A. Di Leo, S. Dolci, P. Francis, D. Larsimont, J. Nogaret, C. Philippson, M. Piccart, S. Linn, P. Peer, V. Tjan-Heijnen, S. Vliek, D. Slamon, J. Bartlett, V. Bramwell, Bingshu E. Chen, S. Chia, K. Gelmon, P. Goss, M. Levine, W. Parulekar, J. Pater, E. Rakovitch, L. Shepherd, D. Tu, T. Whelan, D. Berry, G. Broadwater, C. Cirrincione, H. Muss, Raymond Weiss, Y. Shan, Yong Shao, Xiang Wang, Bing-he Xu, Dong-Bing Zhao, H. Bartelink, N. Bijker, J. Bogaerts, F. Cardoso, T. Čufer, J. Julien, P. Poortmans, E. Rutgers, C. J. van de Velde, E. Carrasco, M. Seguí, J. Blohmer, S. Costa, B. Gerber, C. Jackisch, G. von Minckwitz, M. Giuliano, M. De Laurentiis, C. Bamia, G. Koliou, D. Mavroudis, R. A’Hern, P. Ellis, L. Kilburn, J. Morden, J. Yarnold, M. Sadoon, A. Tulusan, S. Anderson, G. Bass, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. Mamounas, S. Paik, C. Redmond, D. Wickerham, M. Venturini, C. Bighin, S. Pastorino, P. Pronzato, M. Sertoli, T. Foukakis, K. Albain, R. Arriagada, Elizabeth Bergsten Nordström, F. Boccardo, E. Brain, L. Carey, A. Coates, R. Coleman, C. Correa, J. Cuzick, N. Davidson, M. Dowsett, M. Ewertz, J. Forbes, R. Gelber, A. Goldhirsch, P. Goodwin, D. Hayes, C. Hill, J. Ingle, R. Jagsi, W. Janni, H. Mukai, Y. Ohashi, L. Pierce, V. Raina, P. Ravdin, D. Rea, M. Regan, J. Robertson, J. Sparano, A. Tutt, G. Viale, N. Wilcken, N. Wolmark, W. Wood, M. Zambetti	8	2019	8 🐜
🐜	Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane–Anthracycline Containing Chemotherapy—DAFNE (GBG-70) 17 auth. C. Hanusch, A. Schneeweiss, S. Loibl, M. Untch, S. Paepke, S. Kümmel, C. Jackisch, J. Huober, J. Hilfrich, B. Gerber, ... H. Eidtmann, C. Denkert, S. Costa, J. Blohmer, K. Engels, N. Burchardi, G. von Minckwitz	5	2015	5 🐜
🐜	Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0) 10 auth. A. Loehr, G. Minckwitz, G. Raab, M. Schuette, J. Blohmer, J. Hilfrich, ... B. Gerber, S. Costa, A. Caputo, M. Kaufmann	4	2003	4 🐜